Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters
Ying‐Si Wu(National Defense Medical Center), Dah‐Shyong Yü(Tri-Service General Hospital)
Cited by 16
Related Papers
The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol
|Oncology Letters|2019|37